Wetzstein, Nils http://orcid.org/0000-0002-5589-4668
Drummer, Alena-Pauline
Bockey, Annabelle
Herrmann, Eva
Küpper-Tetzel, Claus Philippe
Graf, Christiana
Koch, Benjamin
Goetsch, Udo
Vehreschild, Maria J. G. T.
Guglielmetti, Lorenzo
Lange, Berit
Wichelhaus, Thomas A.
Stephan, Christoph
Funding for this research was provided by:
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 10 May 2022
Accepted: 2 September 2022
First Online: 1 October 2022
Declarations
:
: Nils Wetzstein, Alena-Pauline Drummer, Annabelle Bockey, Eva Herrmann, Claus Philippe Küper-Tetzel, Christiana Graf, Benjamin Koch, Udo Goetsch, Lorenzo Guglielmetti, and Berit Lange have nothing to disclose. Maria J.G.T. Vehreschild received research grants from 3M, Astellas Pharma, Biontech, DaVolterra, Gilead Sciences, MaaT Pharma, Merck/MSD, Organobalance, Seres Therapeutics, and Takeda Pharmaceutical. Speaker fees and/or consulting from: Alb Fils Kliniken GmbH, Arderypharm, Astellas Pharma, Basilea, Bio-Mérieux, DaVolterra, Farmak International Holding GmbH, Ferring, Gilead Sciences, Immunic AG, MaaT Pharma, Merck/MSD, Pfizer, Roche, SocraTec R&D GmbH, and Tillots Pharma. Thomas A. Wichelhaus received research grants from MSD, and Deutsche Krebshilfe, as well as speaker fees/consulting from Insmed, Osartis. Christoph Stephan declares that he has received honorary fees for lectures from AbbVie, Gilead Sciences, Janssen-Cilag, MSD Sharp & Dohme, TAD; in addition, he has received honorary fees for scientific advice from the following pharmaceutical companies: Gilead Sciences, Janssen-Cilag, MSD Sharp & Dohme, and ViiV Healthcare, and financial support for conference travel grants from Gilead Sciences, Janssen-Cilag, Hormosan, and MSD Sharp & Dohme.